Trial Profile
Phase I safety study of ALGRX 1207, a topical local anaesthetic for neuropathic pain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs ALGRX 1207 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 31 Oct 2006 New trial record.